InvestorsHub Logo

DarthYoda

03/23/20 12:02 PM

#14401 RE: ANIA77 #14400

Thanks for info. I see Abacus even has a subsidiary in Israel. Should be great for conducting any clinical trials. I am doing DD now, and am pleasantly surprised by the news today.

To capitalize on the robust life science expertise that Israel has to offer, Abacus has strategically opened a subsidiary in Tel Aviv, which undertakes a number of activities including Research & Development, Marketing, Business Development and International Sales.


https://abacushp.com/innovation/israel/

DarthYoda

03/23/20 12:19 PM

#14402 RE: ANIA77 #14400

Abacus has a nice balance sheet which shows $28,239,000 in cash and cash equivalents, $43,583,000 in assets, and only $7,285,000 in liabilities for last Q report:

Fiscal year ends 12/31 | Values in 000s USD
Cash and Cash Equivalents
28,239


Total Assets
43,583


Total Liabilities
7,285


https://www.otcmarkets.com/stock/ABAHF/financials